About the Trial

The study will be conducted at 15 study sites across the United States. 107 eligible participants from these trial sites will receive the AF treatment.

You may be eligible to participate in the clinical trial:

• If you are between 18 and 80 years of age
• If you have documented longstanding persistent AF for less than 10 years
• If you are scheduled for heart surgery such as bypass surgery or valve repair/replacement

You are not eligible to participate:

• If you have had a previous catheter ablation for AF
• If you have had a previous cardiac surgery

These are the preliminary eligibility criteria to enroll in the study and receive the study procedure for your longstanding persistent AF. To further evaluate your eligibility for study participation, contact your physician or the nearest nContact clinical trial site.

What are the risks of clinical trial participation?

Your physician is the most appropriate person to discuss the risks of this study procedure and other treatment options for your AF.